A carregar...

Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells

Cyclin-dependent kinase inhibitors (CDKIs) are considered as novel anticancer agents because of their ability to induce growth arrest or apoptosis in tumour cells. It has not yet been fully determined, however, which CDKI is the best candidate for the treatment of malignant gliomas and whether norma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Komata, T, Kanzawa, T, Takeuchi, H, Germano, I M, Schreiber, M, Kondo, Y, Kondo, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747579/
https://ncbi.nlm.nih.gov/pubmed/12698196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600862
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!